Development of Ppar-γ Receptor Agonists as Therapeutic Agents for Diabetes
نویسندگان
چکیده
منابع مشابه
PPAR-γ Agonists and Their Effects on IGF-I Receptor Signaling: Implications for Cancer
It is now well established that the development and progression of a variety of human malignancies are associated with dysregulated activity of the insulin-like growth factor (IGF) system. In this regard, promising drugs have been developed to target the IGF-I receptor or its ligands. These therapies are limited by the development of insulin resistance and compensatory hyperinsulinemia, which i...
متن کاملNew Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
Diabetic nephropathy (DN) is a severe complication of diabetes and serves as the leading cause of chronic renal failure. In the past decades, angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs) based first-line therapy can slow but cannot stop the progression of DN, which urgently requests the innovation of therapeutic strategies. Thiazolidinediones (TZDs), ...
متن کاملPseudoginsenoside F11, a Novel Partial PPARγ Agonist, Promotes Adiponectin Oligomerization and Secretion in 3T3-L1 Adipocytes
PPAR γ is a nuclear hormone receptor that functions as a master regulator of adipocyte differentiation and development. Full PPAR γ agonists, such as the thiazolidinediones (TZDs), have been widely used to treat type 2 diabetes. However, they are characterized by undesirable side effects due to their strong agonist activities. Pseudoginsenoside F11 (p-F11) is an ocotillol-type ginsenoside isola...
متن کاملPPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
It is now widely accepted that insulin resistance and compensatory hyperinsulinemia are associated to increased cancer incidence and mortality. Moreover, cancer development and progression as well as cancer resistance to traditional anticancer therapies are often linked to a deregulation/overactivation of the insulin-like growth factor (IGF) axis, which involves the autocrine/paracrine producti...
متن کاملAre partial PPAR gamma agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney ?
Diabetes mellitus is probably the single most important metabolic disease and is widely recognized as one of the leading causes of death and disability. Up to a third of people with diabetes mellitus suffer end-stage renal failure due to diabetic nephropathy. Diabetic nephropathy strategies to delay progression of diabetic nephropathyincluding glycemic and blood pressure control, modification o...
متن کامل